Total Debt
$8.96B
Net Debt
$8.35B
Royalty Pharma plc currently has $8.96B in total debt. Net debt is $8.35B after cash offsets.
Financial Fundamentals
RPRX • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 8.96 | 0.61 | 8.35 | 19.82 | 45.2% |
| 2025-12-31 | 8.95 | 0.64 | 8.31 | 19.62 | 45.6% |
| 2025-09-30 | 8.97 | 0.96 | 8.01 | 19.35 | 46.3% |
| 2025-06-30 | 8.00 | 1.49 | 6.51 | 18.32 | 43.7% |
| 2025-03-31 | 7.62 | 1.82 | 5.80 | 17.61 | 43.3% |
| 2024-12-31 | 7.61 | 1.77 | 5.84 | 18.22 | 41.8% |
| 2024-09-30 | 7.61 | 1.76 | 5.84 | 18.04 | 42.2% |
| 2024-06-30 | 7.60 | 2.55 | 5.05 | 17.66 | 43.1% |
| 2024-03-31 | 6.14 | 1.53 | 4.61 | 16.13 | 38.1% |
| 2023-12-31 | 6.14 | 1.23 | 4.90 | 16.38 | 37.5% |
| 2023-09-30 | 6.13 | 1.68 | 4.45 | 15.86 | 38.7% |
| 2023-06-30 | 7.13 | 2.91 | 4.22 | 17.12 | 41.6% |
| 2023-03-31 | 7.12 | 2.59 | 4.53 | 17.07 | 41.7% |
| 2022-12-31 | 7.12 | 2.43 | 4.69 | 16.81 | 42.3% |
| 2022-09-30 | 7.11 | 2.22 | 4.89 | 17.67 | 40.2% |
| 2022-06-30 | 7.11 | 3.40 | 3.70 | 17.74 | 40.1% |
| 2022-03-31 | 7.10 | 2.91 | 4.19 | 17.38 | 40.9% |
| 2021-12-31 | 7.10 | 2.80 | 4.29 | 17.52 | 40.5% |
| 2021-09-30 | 7.09 | 2.69 | 4.40 | 17.73 | 40.0% |
| 2021-06-30 | 5.83 | 2.65 | 3.18 | 16.51 | 35.3% |
| 2021-03-31 | 5.82 | 2.37 | 3.45 | 15.91 | 36.6% |
| 2020-12-31 | 5.82 | 2.65 | 3.17 | 16.02 | 36.3% |
| 2020-09-30 | 5.81 | 2.73 | 3.08 | 15.99 | 36.3% |
| 2020-06-30 | 5.91 | 3.34 | 2.57 | 15.69 | 37.7% |
| 2020-03-31 | 5.96 | 1.70 | 4.26 | 13.37 | 44.6% |
| 2019-12-31 | 6.24 | 0.79 | 5.44 | 12.45 | 50.1% |
| 2019-03-31 | 0.00 | 1.94 | -1.94Net Cash | 0.00 | — |